Because the downregulation of SFRP2 is a marker of colorectal cancer [44–45], this pattern agrees with known role of immunoglobulin-expressing cells in infiltrating and combating the tumor [46–47]. This evidence concerns the gene SFRP2 and colorectal cancer.